---
name: AmbioPharm
slug: ambiopharm
site: cdmo
website_domain: ambiopharm.com
summary: FDA-inspected peptide API manufacturer offering GMP custom synthesis, process development, analytical method validation, and vaccine peptide manufacturing from preclinical through commercial scale. Headquartered in North Augusta, United States.
tagline: Setting a New Standard for Peptide API Manufacturing and Services
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: CordenPharma
parent_slug: cordenpharma
hq_country: US
tier2_domain_verified: false
updated_at: 2026-08-05T00:03:28.407Z
services_count: 5
modalities_count: 2
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# AmbioPharm

Setting a New Standard for Peptide API Manufacturing and Services

Listed on cdmo.directory.

## Summary

FDA-inspected peptide API manufacturer offering GMP custom synthesis, process development, analytical method validation, and vaccine peptide manufacturing from preclinical through commercial scale. Headquartered in North Augusta, United States.

## At a glance

- Parent: [CordenPharma](/companies/cordenpharma)
- HQ country: US

## Services

- Peptide Manufacturing
- CMC Analytical Development
- Process Development
- Vaccine Manufacturing
- API Synthesis & Manufacturing

## Modalities

- Peptide
- Vaccine

## Locations

- North Augusta, North Augusta, South Carolina, United States

## Long description

AmbioPharm is a specialized peptide API CDMO focused on custom peptide synthesis and manufacturing services for pharmaceutical and biotech companies. The company operates FDA-inspected facilities with more than 500 chemists and industry professionals across two locations, providing services across all phases of development from preclinical to commercialization.

**Core Services:**
- GMP Manufacturing and Custom Peptide Synthesis (solid phase, liquid phase, and hybrid strategies)
- Custom Organic Synthesis
- Biologically Active Peptides
- Non-GMP process development and analytical services
- Vaccine peptide ingredient manufacturing
- Cosmetic peptide formulation and manufacturing
- Analytical Development & Validation (HPLC method development and validation protocols)

**Regulatory & Quality:**
The company emphasizes FDA-inspected quality systems meeting global regulatory standards for clinical and commercial use. Over 200 years of cumulative team experience in process development, scale-up, and GMP manufacturing supports the API Model—designed to accelerate the path from Phase II trials to commercialization.

**Capacity & Growth:**
AmbioPharm is investing $121.9 million to expand its North Augusta, South Carolina campus, bringing commercial-scale peptide API production to U.S. soil by 2027. The company positions itself as one of the largest peptide capacity manufacturers worldwide.

## Related companies

- [PolyPeptide Group](/companies/polypeptide) (Peptide Manufacturing, CMC Analytical Development) — [Compare](/compare/ambiopharm/polypeptide)
- [Bachem](/companies/bachem) (Peptide Manufacturing, CMC Analytical Development) — [Compare](/compare/ambiopharm/bachem)
- [Divi's Laboratories](/companies/divislabs) (Peptide Manufacturing, CMC Analytical Development) — [Compare](/compare/ambiopharm/divislabs)
- [Piramal Pharma Solutions](/companies/piramalpharmasolutions) (Peptide Manufacturing, CMC Analytical Development) — [Compare](/compare/ambiopharm/piramalpharmasolutions)
- [CPC Scientific](/companies/cpcscientific) (Peptide Manufacturing, CMC Analytical Development) — [Compare](/compare/ambiopharm/cpcscientific)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](/companies/sinopep) (Peptide Manufacturing, CMC Analytical Development) — [Compare](/compare/ambiopharm/sinopep)
- [Quotient Sciences](/companies/quotientsciences) (Peptide Manufacturing, CMC Analytical Development) — [Compare](/compare/ambiopharm/quotientsciences)
- [Cytovance Biologics](/companies/cytovance-biologics) (CMC Analytical Development, Process Development) — [Compare](/compare/ambiopharm/cytovance-biologics)

_Profile last updated: 2026-08-05T00:03:28.407Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.